BioSpace News Archive

Epson Robots, the #1 SCARA robot manufacturer in the world, will be demonstrating robotic solutions at SLAS in booth #314.

Ascletis Pharma Inc. announces that the oral presentation at the 2023 annual meeting of the Asian Pacific Association for the Study of the Liver demonstrates that ASC22, a subcutaneous PD-L1 antibody, can achieve functional cure of chronic hepatitis B.

Enthera Pharmaceuticals, a biotech company developing first-in-class biologics for selected autoimmune conditions, announces the appointment of Filippo Canducci MD, PhD as Chief Medical Officer.

Modular Devices, a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions, and portfolio company of O2 Investment Partners, announced that it has partnered with Interim Diagnostic Imaging.

Talaris Therapeutics, Inc., announced that it has completed a review of its business and program prospects.

NexImmune, Inc. announced that new positive, preclinical data will be presented in an abstract titled “Prior Antigen Exposure Enhances the T cell Response to Bispecific T cell Engager Therapy” at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, taking place on February 15-19, 2023 in Orlando, Florida.

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will present at a virtual event co-hosted by BIO and Solve M.E.

Zymtronix and Ginkgo Bioworks announced a partnership to optimize enzymes used in Zymtronix’s proprietary cell-free platform for the production of important ingredients in food, agriculture, cosmetics and pharmaceuticals.

Lutris Pharma announced that Antoni Ribas, M.D., Ph.D., Chairman and Founder of Lutris Pharma, will present a company overview, virtually, at the 16th Annual European Life Sciences CEO Forum on March 8, 2023.

Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2022.